Study ID: SD-809-C-15
Study Title
- First Time Use of SD-809 in Huntington Disease
Teva Identifier
- SD-809-C-15
ClinicalTrials.gov Identifier
- NCT01795859
Study Status
- Completed
Trial Condition(s)
- Chorea
Interventions
- Drug: SD-809 | Drug: Placebo
Study Description
- Please refer to ClinicalTrials.gov for a description of the trial

Key Participation Requirements
Gender
- Female, Male
Age Range
- 18 Years and older
Trial Duration
- 08/05/2013 - 12/05/2014
Phase
- Phase 3
Study Type
Interventional